Cardiometabolic Risk Research Project

This research was undertaken to help AMGA understand current practices in early identification and treatment of a cluster of risk factors that are known to increase patients’ risk of cardiovascular disease and type 2 diabetes. Through a survey of member medical groups we explored:

The views and beliefs of Medical Directors regarding cardiometabolic risk (CMR)
The opportunities for multispecialty medical groups to better manage the clustered risk factors associated with CMR
How healthcare policies and benefits are affecting the way medical groups approach CMR

To access survey click here.

Interesting survey results include:

75% of groups do not have a standard definition of CMR.
Risk factors for obesity, diabetes, and hypertension were perceived to be strongly associated with CMR, while low HDL-C, elevated triglycerides, and elevated LDL-C were less so. Only 68% associated inflammatory markers with CMR.
Medical groups in the Midwest and Northwest were more likely to indicate that their groups had an inconsistent understanding of CMR.
BMI is more likely to be measured and used as an indicator of successful obesity treatment than waist circumference.
Increases in payment levels for obesity treatment would result in more aggressive treatment of patients with CMR.
Time spent educating patients is the treatment action that would most greatly be impacted by increased levels of payment.

To access complete survey results click here.

Website Terms and Conditions of Use and Privacy Policy